Lithium

Lithium

SCHEMBL29779115

Cc1cc(C)c(C(=O)[PH](=O)c2ccccc2)c(C)c1.[Li]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.35
METAP2 P50579 1/20 0.35
HPGD P15428 2/20 0.34
FFAR4 Q5NUL3 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.34
GAA P10253 1/20 0.34
NFE2L2 Q16236 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CRHR1 P34998 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82366 0.98 LMNA (0.40) LMNAKDM4EL3MBTL1KMT2AMEN1
SCHEMBL28781832 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
Potassium SCHEMBL29629366 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
SCHEMBL28100158 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
SCHEMBL1024553 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
SCHEMBL29365769 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
Ammonia Solution, Strong SCHEMBL2909570 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
SCHEMBL1024427 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
SCHEMBL21831853 0.97 LMNA (0.39) LMNAKDM4EL3MBTL1KMT2AMEN1
Benzophenone SCHEMBL28167644 0.91 ALDH1A1 (0.42) LMNAL3MBTL1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114762680-A 3D printing antibacterial hydrogel microparticle and preparation method thereof 中国人民解放军总医院 2022-07-19 CN claimed
EP-3677241-B1 NON-SOLVENT-TYPE ADHESIVE COMPOSITION FOR DENTAL USE KURARAY NORITAKE DENTAL INC (JP) 2023-02-15 EP disclosed
CN-111419183-B Medical blood vessel developing device and system 首都医科大学宣武医院 2022-11-29 CN disclosed
US-11452674-B2 Non-solvent dental adhesive composition KURARAY NORITAKE DENTAL INC. (JP) 2022-09-27 US disclosed
CN-114762680-A 3D printing antibacterial hydrogel microparticle and preparation method thereof 中国人民解放军总医院 2022-07-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11452674-B2 Non-solvent dental adhesive composition CDH1, VCL, MACF1 LMNA 2909/4885KDM4E 4039/4885L3MBTL1 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.